Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE3.9500
- TODAY'S CHANGE (%)-0.5500 (-12.2222%)
- Bid / Lots3.9500/ 1
- Ask / Lots4.0500/ 5
- Open / Previous Close4.5000 / 4.5000
- Day Range
- 52 Week Range
- Volume2,807,274
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 35711 | 4.54 |
| 09:34 ET | 901 | 4.51 |
| 09:36 ET | 6085 | 4.395 |
| 09:38 ET | 1400 | 4.37 |
| 09:39 ET | 6453 | 4.3501 |
| 09:41 ET | 12593 | 4.34 |
| 09:43 ET | 5723 | 4.38 |
| 09:45 ET | 301 | 4.38 |
| 09:48 ET | 2636 | 4.34 |
| 09:50 ET | 4482 | 4.36 |
| 09:56 ET | 3800 | 4.4099 |
| 09:57 ET | 230 | 4.4099 |
| 09:59 ET | 700 | 4.42 |
| 10:01 ET | 300 | 4.42 |
| 10:03 ET | 1000 | 4.42 |
| 10:06 ET | 3900 | 4.41 |
| 10:08 ET | 5138 | 4.395 |
| 10:10 ET | 818 | 4.4 |
| 10:12 ET | 800 | 4.39 |
| 10:14 ET | 4529 | 4.4 |
| 10:15 ET | 435 | 4.38 |
| 10:17 ET | 2275 | 4.395 |
| 10:19 ET | 10752 | 4.31 |
| 10:21 ET | 700 | 4.3105 |
| 10:24 ET | 651 | 4.315 |
| 10:26 ET | 900 | 4.32 |
| 10:28 ET | 400 | 4.31 |
| 10:30 ET | 2800 | 4.32 |
| 10:32 ET | 12700 | 4.295 |
| 10:33 ET | 17044 | 4.305 |
| 10:35 ET | 2681 | 4.305 |
| 10:37 ET | 3815 | 4.31 |
| 10:39 ET | 1859 | 4.31 |
| 10:42 ET | 2131 | 4.305 |
| 10:44 ET | 2700 | 4.3 |
| 10:46 ET | 6565 | 4.3 |
| 10:48 ET | 8056 | 4.302 |
| 10:50 ET | 1100 | 4.305 |
| 10:51 ET | 6442 | 4.304 |
| 10:53 ET | 800 | 4.3 |
| 10:55 ET | 21431 | 4.276 |
| 10:57 ET | 28467 | 4.285 |
| 11:00 ET | 26700 | 4.285 |
| 11:02 ET | 2280 | 4.275 |
| 11:04 ET | 10420 | 4.285 |
| 11:06 ET | 200 | 4.28 |
| 11:08 ET | 1967 | 4.3 |
| 11:09 ET | 100 | 4.295 |
| 11:11 ET | 500 | 4.295 |
| 11:13 ET | 57767 | 4.295 |
| 11:15 ET | 724 | 4.3 |
| 11:18 ET | 1300 | 4.29 |
| 11:20 ET | 6476 | 4.325 |
| 11:22 ET | 8185 | 4.29 |
| 11:24 ET | 3400 | 4.29 |
| 11:27 ET | 500 | 4.295 |
| 11:29 ET | 100 | 4.295 |
| 11:31 ET | 2939 | 4.3 |
| 11:33 ET | 100 | 4.295 |
| 11:36 ET | 4000 | 4.29 |
| 11:38 ET | 300 | 4.29 |
| 11:42 ET | 1965 | 4.29 |
| 11:44 ET | 5170 | 4.2802 |
| 11:45 ET | 10013 | 4.255 |
| 11:47 ET | 2900 | 4.2501 |
| 11:49 ET | 380 | 4.255 |
| 11:51 ET | 14329 | 4.26 |
| 11:54 ET | 2856 | 4.25 |
| 11:56 ET | 1321 | 4.24 |
| 11:58 ET | 2619 | 4.215 |
| 12:00 ET | 3690 | 4.215 |
| 12:02 ET | 8615 | 4.21 |
| 12:03 ET | 1900 | 4.215 |
| 12:05 ET | 200 | 4.22 |
| 12:07 ET | 100 | 4.21 |
| 12:09 ET | 1300 | 4.22 |
| 12:12 ET | 18281 | 4.2 |
| 12:14 ET | 4223 | 4.195 |
| 12:16 ET | 754 | 4.1999 |
| 12:18 ET | 13934 | 4.185 |
| 12:20 ET | 1250 | 4.19 |
| 12:21 ET | 6296 | 4.185 |
| 12:23 ET | 1855 | 4.175 |
| 12:25 ET | 56113 | 4.155 |
| 12:27 ET | 15646 | 4.1284 |
| 12:30 ET | 11157 | 4.125 |
| 12:32 ET | 15550 | 4.13 |
| 12:34 ET | 19739 | 4.13 |
| 12:36 ET | 5731 | 4.1261 |
| 12:38 ET | 6735 | 4.125 |
| 12:39 ET | 8700 | 4.125 |
| 12:41 ET | 123129 | 4.105 |
| 12:43 ET | 145898 | 4.0699 |
| 12:45 ET | 30386 | 4.0902 |
| 12:48 ET | 71830 | 4.0976 |
| 12:50 ET | 5518 | 4.075 |
| 12:52 ET | 8418 | 4.0799 |
| 12:54 ET | 15109 | 4.06 |
| 12:56 ET | 24520 | 4.135 |
| 12:57 ET | 5142 | 4.1391 |
| 12:59 ET | 9806 | 4.14 |
| 01:01 ET | 3148 | 4.14 |
| 01:03 ET | 3399 | 4.15 |
| 01:06 ET | 5451 | 4.17 |
| 01:08 ET | 1701 | 4.17 |
| 01:10 ET | 1150 | 4.165 |
| 01:12 ET | 5272 | 4.13 |
| 01:14 ET | 608 | 4.1264 |
| 01:15 ET | 11064 | 4.1 |
| 01:17 ET | 3393 | 4.1 |
| 01:19 ET | 416 | 4.105 |
| 01:21 ET | 350 | 4.1098 |
| 01:24 ET | 1319 | 4.105 |
| 01:26 ET | 8848 | 4.115 |
| 01:28 ET | 4843 | 4.105 |
| 01:30 ET | 8910 | 4.105 |
| 01:32 ET | 5049 | 4.095 |
| 01:33 ET | 5048 | 4.09 |
| 01:35 ET | 1200 | 4.095 |
| 01:37 ET | 5308 | 4.09 |
| 01:39 ET | 5839 | 4.082 |
| 01:42 ET | 6003 | 4.07 |
| 01:46 ET | 3729 | 4.0788 |
| 01:48 ET | 200 | 4.075 |
| 01:50 ET | 9043 | 4.07 |
| 01:51 ET | 12309 | 4.07 |
| 01:53 ET | 600 | 4.08 |
| 01:55 ET | 1275 | 4.07 |
| 01:57 ET | 9441 | 4.075 |
| 02:00 ET | 17963 | 4.075 |
| 02:02 ET | 7555 | 4.075 |
| 02:04 ET | 3400 | 4.075 |
| 02:06 ET | 6533 | 4.085 |
| 02:08 ET | 6459 | 4.0892 |
| 02:09 ET | 3300 | 4.0899 |
| 02:11 ET | 4599 | 4.0892 |
| 02:13 ET | 600 | 4.08 |
| 02:15 ET | 5753 | 4.085 |
| 02:18 ET | 5553 | 4.085 |
| 02:20 ET | 13273 | 4.07 |
| 02:22 ET | 300 | 4.065 |
| 02:24 ET | 203 | 4.065 |
| 02:26 ET | 600 | 4.065 |
| 02:27 ET | 13856 | 4.07 |
| 02:29 ET | 7619 | 4.06 |
| 02:31 ET | 24018 | 4.0494 |
| 02:33 ET | 1925 | 4.0492 |
| 02:36 ET | 4253 | 4.065 |
| 02:38 ET | 4745 | 4.0601 |
| 02:40 ET | 30659 | 4.1001 |
| 02:42 ET | 5834 | 4.105 |
| 02:44 ET | 5700 | 4.1 |
| 02:45 ET | 400 | 4.1 |
| 02:47 ET | 7000 | 4.055 |
| 02:49 ET | 4673 | 4.05 |
| 02:51 ET | 3079 | 4.04 |
| 02:54 ET | 5508 | 4.045 |
| 02:56 ET | 3000 | 4.045 |
| 02:58 ET | 6300 | 4.045 |
| 03:00 ET | 12716 | 4.05 |
| 03:02 ET | 1325 | 4.055 |
| 03:03 ET | 25717 | 4.075 |
| 03:05 ET | 35194 | 4.0598 |
| 03:07 ET | 1355 | 4.0599 |
| 03:09 ET | 11052 | 4.065 |
| 03:12 ET | 3805 | 4.065 |
| 03:14 ET | 340 | 4.07 |
| 03:16 ET | 2010 | 4.065 |
| 03:18 ET | 2697 | 4.06 |
| 03:20 ET | 8290 | 4.05 |
| 03:21 ET | 10646 | 4.04 |
| 03:23 ET | 3900 | 4.0491 |
| 03:25 ET | 67992 | 4.025 |
| 03:27 ET | 7541 | 4.025 |
| 03:30 ET | 5226 | 4.025 |
| 03:32 ET | 29755 | 4.01 |
| 03:34 ET | 31518 | 4.0001 |
| 03:36 ET | 95730 | 3.885 |
| 03:38 ET | 157730 | 3.955 |
| 03:39 ET | 42326 | 3.9509 |
| 03:41 ET | 18027 | 3.945 |
| 03:43 ET | 31023 | 3.935 |
| 03:45 ET | 19603 | 3.915 |
| 03:48 ET | 34930 | 3.92 |
| 03:50 ET | 33430 | 3.925 |
| 03:52 ET | 24336 | 3.925 |
| 03:54 ET | 85473 | 3.945 |
| 03:56 ET | 31038 | 3.965 |
| 03:57 ET | 44147 | 3.95 |
| 03:59 ET | 187810 | 3.95 |
Today
Yesterday
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 12:21PM ET on Monday Sep 16, 2024 by Dow Jones
12:21PM ET on Monday Sep 16, 2024 by Dow Jones
Sep 12, 2024
Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference, from 5:35PM ET on Thursday Sep 12, 2024 by Dow Jones
5:35PM ET on Thursday Sep 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 692.3M | -12.0x | --- |
Immunome Inc | 948.3M | -2.7x | --- |
Oruka Therapeutics Inc | 906.5M | -4.4x | --- |
4D Molecular Therapeutics Inc | 856.5M | -7.3x | --- |
Perspective Therapeutics Inc | 884.7M | -9.6x | --- |
IGM Biosciences Inc | 939.6M | -4.8x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). In addition to the rare disease programs, it has two oncology product candidates in clinical development. Etigilimab is an IgG1 monoclonal antibody which binds to the human T-cell immunoreceptor with Ig and ITIM domains (TIGIT) receptor on immune cells to improve the activation and effectiveness of T-cell and NK cell antitumor activity. Navicixizumab is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Navicixizumab is developed for the treatment of late line ovarian cancer.
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $692.3M |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 153.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.98 |
EPS | $-0.33 |
Book Value | $0.46 |
P/E Ratio | -12.0x |
Price/Sales (TTM) | 66.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
